StonvexLoading…
StonvexStonvexStonvexCore line items from IHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.58B | $1.53B | $1.93B | $1.96B |
Operating Income | $821.40M | $604.00M | $524.40M | $312.25M |
Net Income | $126.80M | $-1.64B | $-1.99B | $-468.97M |
EPS (Diluted) | $0.42 | $-4.90 | $-5.93 | $-1.39 |
Total Assets | $4.49B | $4.25B | $5.33B | $6.32B |
Total Liabilities | $4.58B | $4.56B | $5.01B | $4.96B |
Cash & Equivalents | $825.70M | $578.00M | $293.82M | $514.08M |
Free Cash Flow OCF − CapEx | $718.70M | $494.20M | $388.60M | $528.78M |
Shares Outstanding | 335.52M | 333.44M | 332.52M | 331.92M |